Sensex and Nifty Performance Overview

The benchmark Sensex opened sharply lower by 532.83 points and extended losses throughout the day, settling below its 50-day moving average (DMA). The 50 DMA itself remains below the 200 DMA, signalling a cautious technical backdrop. The Nifty mirrored this trend, with the broader market indices also under pressure. The S&P BSE 100 index fell by 0.65%, while the midcap and smallcap indices declined by 0.14% and 0.09% respectively, indicating a broad-based sell-off across market capitalisation segments.

Sectoral Trends: Winners and Losers

Out of 37 sectors tracked, only 11 advanced while 26 declined, underscoring a predominantly bearish market mood. The NIFTYPHARMA sector emerged as the top gainer, surging 2.54% and hitting a new 52-week high. This rally was led by strong performances in large-cap pharmaceutical stocks, reflecting renewed investor interest amid upcoming earnings and positive global cues in healthcare.

Energy-related indices also performed well, with the S&P BSE Power and NIFTY ENERGY indices reaching fresh 52-week highs, supported by robust demand outlook and stable commodity prices. The capital goods sector similarly recorded gains, buoyed by select industrial stocks showing resilience.

Conversely, the NIFTYPSUBANK sector was the worst performer, plunging 2.26% as concerns over asset quality and credit growth weighed on investor sentiment. Financial stocks broadly faced selling pressure, with private sector banks and non-banking financial companies (NBFCs) among the laggards.

Top Gainers and Losers Across Market Caps

Among the BSE500 constituents, Dr Reddy's Laboratories led the large-cap gainers with a robust 10.39% jump, driven by positive anticipation ahead of earnings and favourable global pharmaceutical trends. Midcap stocks like Oracle Financial Services gained 7.80%, while small caps such as Praj Industries rose 8.04%, reflecting selective buying in quality names.

On the downside, IIFL Finance was the top small-cap loser, plunging 8.75%, followed by Union Bank of India down 7.78%, and Havells India falling 6.73% among large caps. Midcap laggards included Ashok Leyland, which declined 4.97%, highlighting sector-specific challenges in auto and financial services.

Market Breadth and Capital Flows

The advance-decline ratio on the BSE500 stood at 211 advances against 287 declines, translating to a ratio of 0.74x, signalling a market dominated by sellers. This negative breadth was consistent with the broader indices’ downward trajectory.

Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) activity remained subdued, with cautious positioning ahead of major corporate results from Reliance Industries, Shriram Finance, and Hindustan Zinc scheduled for 24 Apr 2026. Global cues were mixed, with Asian markets showing modest gains while European indices traded flat, reflecting ongoing geopolitical uncertainties and macroeconomic data releases.

Technical and Sentiment Analysis

The technical setup remains cautious as the Sensex trades below its 50 DMA, which itself is positioned below the 200 DMA, a classic bearish signal. This suggests that the market may face resistance near current levels unless supported by strong earnings or macroeconomic data. The mixed sectoral performance indicates selective buying rather than broad-based enthusiasm, with investors favouring defensive and growth-oriented sectors such as pharmaceuticals and energy.

Sentiment is also being tempered by the upcoming quarterly results of heavyweight companies like Reliance Industries and Shriram Finance, which are expected to set the tone for the market’s near-term direction. Investors are advised to monitor these earnings closely, as any surprises could trigger significant market moves.

Global Market Influence

Global markets exhibited a cautious tone, with Asian indices posting modest gains while European markets remained largely flat. This mixed global backdrop, combined with ongoing geopolitical tensions and inflation concerns, has contributed to the subdued risk appetite among Indian investors. The cautious stance of foreign investors is reflected in the muted FII flows, which have been a key driver of market momentum in recent months.

Outlook and Investor Takeaways

With the market currently in a consolidation phase, investors should exercise caution and focus on quality stocks with strong fundamentals and resilient earnings prospects. The pharmaceutical and energy sectors continue to offer relative strength and may provide defensive plays amid volatility. Meanwhile, the financial sector’s weakness warrants selective stock picking, especially given the challenges faced by NBFCs and public sector banks.

Upcoming earnings from Reliance Industries, Shriram Finance, and Hindustan Zinc will be critical in shaping market sentiment. Positive surprises could reinvigorate buying interest, while disappointments may extend the current correction. Investors should also keep an eye on global developments and domestic macroeconomic indicators for cues on the broader market direction.

Summary

The Indian equity market closed lower on 23 Apr 2026, with the Sensex down 0.82% amid mixed sectoral performances and subdued breadth. While pharma and energy sectors hit new highs, financials and consumer discretionary stocks lagged. Market participants remain cautious ahead of key earnings and global uncertainties, suggesting a selective approach to stock selection in the near term.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today